Skip to main content
. 2016 Apr 18;5:11. doi: 10.1186/s40164-016-0040-7

Table 2.

Responses based on IMWG criteria

Variable Pomalidomide plus dexamethasone (N = 36)
Response rate, n (%)
 Overall response 15 (41.7)
  Complete response 1 (2.8)
  Very good partial response 0
  Partial response 14 (38.9)
 Stable disease 16 (44.4)
 Progressive disease 5 (13.9)
 Not evaluable 0
Time to response, median (range), months 1.9 (0.9–5.5)
Duration of response, median (range), months Not reached (1.9–11.1)

IMWG International Myeloma Working Group